Retinal Detachment Risks in Diabetic Patients
How Diabetes Leads to Retinal Detachment
Retinal detachment in people with diabetes does not happen suddenly or without warning. It develops through a predictable sequence of events that begins with diabetic retinopathy, which is damage to the blood vessels in the retina (the light-sensitive tissue at the back of the eye) caused by high blood sugar over time.
As diabetic retinopathy advances, retinal blood vessels become increasingly damaged and areas of the retina lose their blood supply. In response, the retina releases growth factors that trigger new, abnormal blood vessel growth on its surface. This advanced stage is called proliferative diabetic retinopathy, or PDR. These new vessels are fragile and prone to bleeding, but they also bring something equally dangerous: fibrous scar tissue that grows alongside them.
The scar tissue, also called fibrovascular tissue, forms along the retinal surface and extends into the vitreous (the gel-like substance that fills the inside of the eye). Over time, this scar tissue contracts, much the way a scar on skin tightens as it matures. As it contracts, it pulls on the retina. If the pulling force is strong enough, it can separate the retina from the tissue that supports and nourishes it. This is called a tractional retinal detachment, or TRD. Unlike other types of retinal detachment, tractional detachment does not require a tear in the retina. The retina is literally being pulled away from the back of the eye by contracting scar tissue.
In some cases, the mechanical pulling from diabetic scar tissue creates enough stress on the retina to cause a tear. When a tear forms, fluid from inside the eye seeps through it and under the retina, adding a rhegmatogenous (tear-based) component to the existing tractional detachment. This combined type is particularly serious because fluid accumulation can cause the detachment to spread more rapidly. The presence of both traction and a retinal tear also makes surgical repair more complex, which is one reason early detection is so important.
When abnormal new blood vessels are accompanied by bleeding into the vitreous, or when new vessel growth is extensive near the optic disc, the condition is classified as high-risk proliferative diabetic retinopathy. At this stage, the risk of vitreous hemorrhage (bleeding inside the eye), tractional retinal detachment, and severe vision loss is significantly elevated. Without treatment, high-risk PDR can progress to what is known as advanced diabetic eye disease, the end-stage of uncontrolled retinopathy. Timely treatment with laser therapy and anti-VEGF injections (medications that block the growth factor driving abnormal vessel formation) at the proliferative stage is critical for preventing detachment.
Warning Signs to Recognize
Because early tractional detachment often causes no pain, knowing what visual changes to look for is essential. Some symptoms develop gradually, while others appear suddenly and require urgent evaluation the same day.
A tractional retinal detachment from diabetes is not painful. Symptoms are entirely visual. You may notice a gradual decrease in overall vision, or that images look distorted or blurred in a specific area. If the detachment involves or threatens the macula (the central part of the retina responsible for sharp, detailed vision), you may have increasing difficulty reading, recognizing faces, or seeing fine details. Some people describe a shadow or dark area in their side vision that seems to slowly expand.
Certain events can cause rapid worsening and should be treated as a potential emergency, especially if you have a known history of proliferative retinopathy.
- A sudden shower of new floaters, especially dark ones, may indicate that scar tissue has pulled on a blood vessel and caused bleeding inside the eye
- Flashes of light in your peripheral (side) vision suggest the retina is being pulled or stimulated by traction
- A dark shadow or curtain-like effect moving across your visual field is a classic sign of a progressing retinal detachment
Any of these symptoms in a person with diabetes warrant same-day contact with your eye doctor or retina specialist.
If a tractional detachment begins in the peripheral retina, away from the macula, you may not notice any change in your day-to-day vision initially. Central vision, which you use for reading and detailed tasks, can remain clear while the detachment is confined to the edges of the retina. This is precisely why regular dilated eye exams are so important. Your eye doctor can see tractional changes and early detachments in the peripheral retina during an exam, even when you are experiencing no symptoms at all.
If you have been diagnosed with proliferative diabetic retinopathy, your eye doctor will monitor you closely for signs of worsening traction and early detachment. Imaging tools play a key role in this process.
- Optical coherence tomography (OCT) is a non-invasive imaging test that shows whether the retina is being pulled or elevated by traction
- B-scan ultrasound can evaluate the retina when a vitreous hemorrhage blocks the direct view
- Wide-field retinal photography documents changes over time and helps track the location of fibrovascular tissue
This ongoing surveillance allows your care team to recommend treatment at the optimal time, before a detachment causes irreversible damage.
Treatment for Diabetic Retinal Detachment
When a tractional retinal detachment requires surgical intervention, the goal is to release the pulling force on the retina, reattach it, and treat the underlying retinopathy to reduce the risk of recurrence. Treatment decisions are always guided by your retina specialist based on the specific characteristics of your condition.
Vitrectomy is the primary surgical treatment for tractional retinal detachment caused by diabetic eye disease. During the procedure, the surgeon removes the vitreous gel from inside the eye along with any blood and scar tissue. Removing the scar tissue releases the traction on the retina, allowing it to settle back into its normal position. The vitreous cavity is then filled with a clear saline solution, a gas bubble, or silicone oil to help support the retina while it heals. The surgeon may also apply laser treatment to the retina during the procedure to reduce the risk of future abnormal blood vessel growth.
Not every tractional retinal detachment requires immediate surgery. If the detachment is limited to the peripheral retina, is stable, and is not threatening the macula, close monitoring may be appropriate. Surgery is typically recommended in the following circumstances:
- The detachment involves or is approaching the macula
- The detachment is progressing despite other treatment
- A combined tractional and rhegmatogenous detachment is present
- Vitreous hemorrhage prevents adequate visualization and monitoring of the retina
The decision to operate is based on the location, extent, and activity of the detachment, as well as the overall health of your eye.
Recovery from vitrectomy surgery varies depending on the complexity of the procedure. If a gas bubble was placed in your eye, you may need to maintain a specific head position for several days to weeks to keep the bubble in contact with the reattached retina. The gas bubble gradually dissolves on its own over weeks. If silicone oil was used, a second procedure to remove the oil may be needed at a later date. Vision improvement after surgery can be gradual and may continue over weeks to months.
The visual outcome of retinal reattachment surgery depends on several factors, including whether the macula was involved, how long the detachment was present before surgery, and the overall health of the retina. When the detachment is caught before it reaches the macula and surgery is performed promptly, outcomes are generally better. If the macula was detached for a prolonged period, some degree of permanent central vision loss may remain even after successful reattachment. Maintaining good blood sugar control before and after surgery supports healing and helps reduce the risk of recurrence.
Preventing Retinal Detachment
The most effective approach to diabetic retinal detachment is prevention. Treating proliferative retinopathy before extensive scar tissue develops, managing systemic risk factors, and staying consistent with eye care are the most powerful tools available.
Panretinal photocoagulation (PRP), a type of laser treatment, reduces the oxygen demand of the peripheral retina and causes abnormal blood vessels to regress. Anti-VEGF injections block the growth factor that drives abnormal vessel formation. These treatments, used alone or together, can halt the progression of PDR and significantly reduce the accumulation of fibrovascular tissue that leads to tractional detachment. Patients with high-risk PDR should receive prompt treatment with both approaches.
Consistent blood sugar management slows the progression of diabetic retinopathy at every stage. Keeping blood sugar within your target range reduces ongoing damage to retinal blood vessels and lowers the chance that your retinopathy will advance to the proliferative stage. Blood pressure control is equally important, as elevated blood pressure puts additional strain on already weakened retinal vessels and can accelerate abnormal vessel growth and scar tissue formation. Managing both risk factors together provides the strongest protection.
Regular dilated eye exams catch the progression of retinopathy at the stages where treatment is most effective. Skipping exams allows retinopathy to progress silently, and by the time symptoms appear, the disease may have already reached an advanced stage. Annual dilated exams are the minimum for anyone with diabetes, and more frequent visits are recommended once retinopathy is present. Consistent monitoring is one of the most powerful tools for preventing retinal detachment.
Preventing retinal detachment is not a single event but a continuing process. When early proliferative changes are detected, your retina specialist may begin anti-VEGF injections to suppress abnormal vessel growth, followed by laser treatment for longer-lasting control. After the initial course of treatment, regular follow-up appointments allow your doctor to confirm that the retinopathy remains stable and to address any new areas of vessel growth before they lead to scar tissue. Staying consistent with your treatment plan, even when your vision feels unchanged, is essential for maintaining your retina's structural integrity over time.
How Diabetic Detachment Differs From Other Types
Not all retinal detachments are alike. Understanding the difference between diabetic tractional detachment and other types helps explain why treatment for diabetic patients often involves a more complex approach.
The most common type of retinal detachment in the general population is rhegmatogenous detachment, caused by a tear or hole in the retina that allows fluid to seep underneath and separate it from its support. In diabetic patients, the predominant type is tractional, driven by scar tissue pulling the retina away without a tear initially being present. The distinction matters because the surgical approach differs. Rhegmatogenous detachments are typically repaired by sealing the retinal tear and removing the fluid, while tractional detachments require careful removal of scar tissue to release the pulling force on the retina. In some diabetic eyes, both types are present at the same time.
Surgery for diabetic tractional retinal detachment is generally more involved than surgery for a standard rhegmatogenous detachment. The scar tissue must be carefully dissected from the retinal surface without causing additional damage to the delicate tissue underneath. Bleeding from the abnormal blood vessels embedded in the scar tissue can occur during the procedure and must be controlled. The retina in a diabetic eye may also be thinner and more fragile from years of compromised blood supply, requiring precise microsurgical technique throughout the procedure.
After successful reattachment surgery, diabetic eyes carry a higher risk of recurrence than non-diabetic eyes. The underlying proliferative retinopathy can continue to generate new scar tissue and abnormal blood vessels if not adequately controlled. Ongoing treatment of the underlying retinopathy with laser and anti-VEGF therapy after surgery is essential. Close follow-up in the months and years following surgery helps your retina specialist detect and address new problems before they lead to a repeat detachment.
Frequently Asked Questions
These answers address common questions and decision points that arise for patients managing diabetic eye disease and navigating concerns about retinal detachment.
The urgency depends on how extensive the traction is, whether it is progressing, and how close it is to the macula. Mild, stable peripheral traction is often monitored closely rather than treated surgically right away. However, if traction is worsening or beginning to threaten the macula, your retina specialist may recommend earlier intervention to prevent full detachment from occurring. The most important thing is to keep your scheduled follow-up appointments so that any changes are detected quickly and a plan can be made before the situation becomes an emergency.
Yes, unfortunately. Scar tissue that has already formed from previous proliferative retinopathy does not disappear when blood sugar improves. Improved blood sugar control is critically important for slowing further progression and supporting healing after treatment, but it does not undo existing fibrovascular tissue or reverse traction that is already present. This is why early treatment of active proliferative retinopathy matters even if systemic control improves, because the structural changes from past disease activity remain.
Not necessarily. A vitreous hemorrhage (bleeding into the gel of the eye) in a diabetic patient often results from fragile abnormal blood vessels rupturing without a retinal detachment being present. However, a hemorrhage can also accompany or follow a tractional detachment, and it can make it difficult for your doctor to see the retina clearly to determine what is happening underneath. If you experience a sudden onset of floaters, vision loss, or a reddish tint, you should contact your eye doctor or retina specialist promptly so that an ultrasound can be performed if needed to evaluate the retina behind the hemorrhage.
Vision recovery after vitrectomy for diabetic retinal detachment is often gradual. Some patients notice improvement within weeks, while others continue to improve over several months as swelling resolves and the retina stabilizes. If a gas bubble was used, vision will remain blurry until the bubble dissolves, which typically takes several weeks. Your retina specialist will give you realistic expectations based on whether your macula was involved, how long the detachment was present, and the overall health of your retinal tissue before surgery.
If a gas bubble was placed in your eye during surgery, flying is not safe until the bubble has fully dissolved. The change in cabin pressure at altitude can cause the gas bubble to expand rapidly, which can dramatically and dangerously raise the pressure inside your eye. Your retina specialist will tell you exactly when it is safe to fly based on the type of gas used and how quickly it is absorbing. Silicone oil does not carry this restriction, but you should always confirm travel safety with your surgeon before making plans after any retinal procedure.
Anti-VEGF injections are highly effective at suppressing abnormal blood vessel growth and can cause significant regression of neovascularization in the short term. However, their effect is temporary and requires ongoing treatment to sustain. Panretinal photocoagulation laser provides a more permanent reduction in the stimulus for abnormal vessel growth and is considered a cornerstone of treatment for high-risk proliferative diabetic retinopathy. Most retina specialists use both approaches together for patients at highest risk of detachment, with the specific combination depending on your individual circumstances and disease severity.
Protecting Your Vision With Specialized Retina Care
Diabetic retinal detachment is a serious complication, but with the right care team and consistent follow-through, many patients are able to preserve meaningful vision. At Rhode Island Eye Institute, our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, bring focused expertise and advanced surgical technology to every case, from early monitoring to complex vitrectomy surgery. We are proud to serve patients across Rhode Island who are navigating the challenges of diabetic eye disease, and we welcome the opportunity to be your trusted partner in protecting your vision for the long term.